This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

CareFirst files third amended US complaint against J&J in case over Stelara

( October 24, 2025, 19:40 GMT | Official Statement) -- MLex Summary: CareFirst filed its third amended US antitrust complaint accusing Johnson & Johnson of unlawfully delaying the introduction of biosimilar competition for Stelara, a treatment for autoimmune diseases. According to the complaint, J&J implemented a scheme to prolong patent protection for Stelara well beyond September 2023 to avoid losing exclusivity over Stelara and maintain overly high prices.See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections